How to Write a Winning IVF Denial Appeal Letter

An IVF denial appeal letter is not a complaint — it is a formal legal document that initiates a dispute process with a health plan, and it is evaluated against the payer's own written medical necessity criteria by a clinical reviewer who may have limited knowledge of reproductive endocrinology. The difference between a fertility practice that recovers 60% of its denied IVF claims on appeal and one that recovers 20% comes down almost entirely to the quality of the appeal letter and the clinical documentation submitted alongside it. Generic templates, missing payer policy citations, and appeals written against the wrong denial classification are the three factors responsible for the majority of IVF appeal failures. This guide covers the process that consistently produces the highest overturn rates: how to correctly classify the denial before writing anything, where to find the payer's own medical necessity standards, what clinical documentation the letter must reference, and how to handle payer-specific procedural requirements that affect Aetna, Cigna, United Healthcare, and BCBS appeals differently.

Step 1: Classify the Denial Before Writing a Word

The most consequential step in IVF appeal writing is correctly classifying the denial type before drafting any letter. There are two fundamentally different denial categories in fertility billing, and they require entirely different responses. Administrative denials — caused by billing errors, missing information, incorrect code selection, or system edits — must be corrected and resubmitted as corrected claims, not formally appealed. Sending a formal written appeal for an administrative denial wastes the appeal window, delays resolution by 30–60 days while the letter sits in the appeals department rather than the claims department, and does nothing to fix the underlying billing error. Clinical or medical necessity denials — where the payer's determination is that the service was not medically necessary, not covered under the plan's benefit structure, or requires clinical documentation to establish coverage — require formal written appeals with organized clinical supporting documents.

The Claim Adjustment Reason Code (CARC) on the Explanation of Benefits is your primary classification tool. CO-50 (not medically necessary), CO-167 (diagnosis inconsistent with the procedure), and CO-96 used with clinical denial language all indicate clinical denials requiring formal appeal. CO-4 (procedure inconsistent with modifier or place of service), CO-15 (authorization number missing or invalid), CO-16 (claim lacks required information), and CO-97 (bundling edit or payment included in another service) indicate administrative corrections that should be resolved by corrected claim resubmission rather than formal appeal. Misidentifying a CO-15 denial as a CO-50 denial — and writing a medical necessity appeal for a missing authorization number — is one of the most common and avoidable errors in fertility billing AR management, and it burns the appeal window on an issue the appeals department cannot resolve.

Step 2: Obtain the Payer's Current Medical Necessity Policy Document

Every major commercial payer publishes clinical policy bulletins or coverage determination guidelines specifying the exact criteria a patient must meet before IVF is considered medically necessary under that plan. These documents are the most valuable resource available for writing IVF appeals because they tell you precisely what the payer's clinical reviewers are evaluating — and an appeal letter that mirrors the payer's own criteria language while documenting the patient's specific clinical facts will consistently outperform a generic letter that does not reference those criteria at all. Obtain the current version of the applicable policy document before writing the appeal. Payer policies update quarterly, and an appeal citing an outdated policy version or citing a different payer's policy by error signals immediately that the letter was not written with knowledge of the specific applicable coverage standard, undermining the letter's credibility from the first paragraph.

• Aetna: Clinical Policy Bulletin (CPB) 0327, "Infertility Testing and Treatment" — available publicly at aetna.com/cpb under the Reproductive Medicine section; covers authorization criteria for CPT 58970 (follicle puncture for oocyte retrieval), 58974 (embryo transfer), embryology lab codes 89250–89281, and PGT; specifies required infertility duration (12 months for women under 35, 6 months for women 35–37, with diagnosis-specific exceptions for documented tubal factor, premature ovarian insufficiency, and severe male factor), and lists the specific ICD-10 codes Aetna recognizes as meeting medical necessity criteria for covered IVF cycles
• United Healthcare: Coverage Determination Guideline (CDG) CS-0037.D, "Infertility Diagnosis and Treatment" — available through the UHC provider portal (uhcprovider.com) or Optum Clinical Policies section; specifies covered IVF indications including tubal factor (N97.1), severe male factor (N46.021–N46.129), diminished ovarian reserve (E28.39), premature ovarian failure (E28.310–E28.319), and documents the number of failed IUI cycles required before IVF is authorized for diagnoses where IUI is clinically appropriate as a first-line fertility intervention
• Cigna: Coverage Policy 0527, "Infertility Services" — available at cigna.com/healthcareproviders under Clinical Coverage Policies; details medical necessity criteria for IVF, employer plan-specific cycle limits, diagnosis-specific infertility requirements, and the specific prior treatment documentation Cigna requires before IVF authorization is granted; for most commercial plans, Cigna requires documentation of 3–6 failed IUI cycles with ovarian stimulation for diagnoses where IUI is medically appropriate before advancing to IVF
• Blue Cross Blue Shield: Medical Policy varies significantly by state plan and by whether the patient's employer is self-funded or fully insured under state law; access through the applicable state plan's provider portal; for BlueCard inter-plan claims, the home plan's medical policy and appeal deadlines govern the claim — do not apply the local state plan's criteria or appeal timeline to a BlueCard patient whose home plan is in a different state with different fertility coverage standards
• Humana: Medical Policy HUM-0052 or equivalent clinical coverage policy available through the Humana provider portal; verify whether the specific employer group has a fertility benefit carve-out through Progyny, WINFertility, or another FBM before submitting an appeal to Humana's standard clinical appeal path — fertility carve-out claims must be appealed through the FBM's portal and appeal process, not through Humana, and misrouted appeals are returned unreviewed after significant delay

Step 3: Compile the Clinical Documentation Package

The appeal letter is only as strong as the clinical documentation submitted alongside it. A letter that makes a compelling medical necessity argument without supporting documentation that independently proves the clinical facts stated in the letter will fail at review — clinical reviewers cannot verify arguments that are not supported by attached records, and a well-argued letter without documentation is typically denied more quickly than a modestly written letter with complete records organized to match the payer's criteria. Before drafting the letter, compile the full clinical documentation package and organize it to correspond with the specific criteria in the payer's policy document, so that the reviewer can move directly from each criterion cited in the letter to the numbered exhibit that proves the patient meets it.

• Complete infertility history note from the treating REI physician documenting the duration of infertility, the primary and contributing diagnoses using ICD-10 terminology, prior treatments attempted with dates and clinical outcomes, and the rationale for recommending IVF — the note must explicitly state the number of months of documented infertility and use clinical language that maps directly to the ICD-10 codes submitted on the claim; a note that uses different terminology than the submitted diagnosis codes gives the reviewer grounds to question whether the codes accurately represent the clinical situation
• Diagnostic test results supporting the infertility diagnosis: day 3 FSH, AMH, and antral follicle count results with test dates for diminished ovarian reserve cases (E28.39, AMH typically below 1.0 ng/mL or 7.14 pmol/L); HSG report or operative laparoscopy report confirming tubal pathology for tubal factor cases (N97.1); saline infusion sonography or hysteroscopy report for uterine factor cases (N97.2); semen analysis with WHO 6th Edition reference value comparisons for male factor cases (N46.x)
• Prior treatment documentation: cycle summary reports, medication administration records, or clinical notes documenting all IUI cycles attempted before IVF was recommended, including ovarian stimulation protocol used, peak follicle count and estradiol levels, insemination date, and outcome — the most frequent reason Aetna, UHC, and Cigna deny IVF on first review is insufficient documentation of prior IUI attempts for diagnoses where IUI is a required first-line step in the payer's medical necessity criteria
• UM authorization denial letter from the payer's utilization management department: the denial letter specifies exactly which criteria the payer found unmet, which is the most precise guide available for structuring the appeal argument; never write an IVF appeal without first reading the UM denial letter, which is distinct from and more diagnostically useful than the generic CARC code on the EOB
• Physician attestation letter from the treating REI physician directly addressing why IVF is the most clinically appropriate treatment for this patient at this time — the attestation is a direct medical opinion statement signed by the physician that functions as physician testimony in the appeal record; it carries more authority with payer medical directors than a billing department narrative and should specifically address the diagnosis, the failure of prior interventions, and the clinical basis for IVF rather than recapitulating the clinical history note
• Current plan Summary Plan Description (SPD) if the denial implicates a plan exclusion the practice believes is ambiguous or being applied incorrectly — self-funded ERISA plans can be appealed on plan language interpretation grounds, and the SPD is the operative document for that argument; obtain through the patient, the employer HR department, or legal counsel if plan language interpretation is the basis of the dispute

ICD-10 Codes Most Often Cited in Successful IVF Denial Appeals

Structure of a Winning IVF Appeal Letter

A formal IVF appeal letter has a specific structure that payer appeal reviewers expect, and deviating significantly from it creates avoidable processing friction. An unbroken narrative without logical headers, or a letter missing required identifiers like the claim number, member ID, and denied CPT codes, causes routing delays and gives the reviewer grounds to request additional information before the letter is evaluated on the merits of the clinical argument. The following required elements apply to first-level internal appeals for IVF medical necessity denials at all major commercial payers.

• Header block at the top of the letter: patient full legal name, date of birth, member ID number, group number, employer plan name, date of service for each denied claim line, CPT code(s) denied (e.g., CPT 58970, CPT 58974, CPT 89250), and the total dollar amount denied — this block must appear before the salutation so the appeal can be routed to the correct member account by the intake team without a manual research step
• Opening paragraph identifying the denial: one to two sentences stating the date of the denial EOB or UM determination letter, quoting the payer's stated denial reason verbatim where possible, and identifying the specific determination being contested; example: "We are appealing the denial of CPT 58970 and CPT 58974 rendered on [date of service] for [member name] (Member ID [number]), denied by [Payer Name] as not medically necessary per [Payer Name] Clinical Policy [number and title]. This determination does not accurately reflect the patient's clinical presentation as documented in the attached records, and we respectfully request reversal and processing for payment"
• Clinical history section: one to two structured paragraphs documenting the patient's infertility diagnosis and ICD-10 code basis, duration of infertility with explicit month count, all prior treatments attempted with dates and documented outcomes, and the clinical rationale for IVF as the most appropriate treatment — each criterion in the payer's medical necessity policy must be explicitly addressed in this section, with a citation to the specific numbered exhibit in the documentation package that proves the patient meets that criterion
• Payer policy citation section: quote the specific subsection of the payer's medical necessity policy that lists the criteria for covered IVF, then demonstrate criterion by criterion that the patient satisfies each applicable requirement; an appeal letter that mirrors the payer's own policy language while substituting the patient's specific clinical facts trains the appeal reviewer to evaluate the case within the existing policy framework rather than as a novel clinical coverage question, and produces materially higher overturn rates than appeals that do not reference the payer's criteria document
• Supporting documentation exhibit index: a sequentially numbered list of every document attached to the appeal packet, with a brief description of each document and the specific appeal criteria it supports; high-volume payer appeal reviewers at carriers like UHC and Aetna process dozens of appeal packets daily, and a clear numbered index that corresponds to in-letter citations reduces the time required to locate supporting evidence and reduces the risk that a document is overlooked during clinical review
• Closing paragraph with specific request and response timeline: a direct request for reversal of the denial and reprocessing of the denied services for payment, the date the appeal is filed, a request for written confirmation of receipt, and a statement of the response deadline the payer is required to meet under state law or ERISA — 30 days for non-urgent internal appeals and 72 hours for urgent or expedited appeals under most state mandates and ACA market rules
• Physician signature block: the attending REI physician must sign the appeal letter or an accompanying physician attestation statement; unsigned appeals can be returned on procedural grounds by payers requiring physician attestation for clinical necessity disputes, and appeals signed only by billing staff may carry reduced authority in clinical review — the physician's signature is both a procedural requirement and a signal to the payer's medical director that the clinical argument is physician-endorsed, not purely administrative

Payer-Specific Appeal Submission Requirements

When to Request a Peer-to-Peer Review

A peer-to-peer review is a direct phone call between the treating REI physician and the payer's assigned medical director — and it is arguably the most powerful single tool available for overturning IVF medical necessity denials at the first appeal level. Peer-to-peer calls are significantly underutilized in fertility billing despite producing overturn rates consistently in the range of 40–55% for fertility cases when the REI physician enters the call prepared with the patient's specific clinical summary, the payer's denial criteria language, and where applicable, published clinical literature supporting IVF for that patient's diagnosis. The peer-to-peer request must be filed within the payer's specified window — typically 10–15 business days from the UM authorization denial for prospective denials — and the call itself must be scheduled and completed before the written appeal window closes if the practice intends to file a concurrent written appeal as backup.

For Aetna, peer-to-peer requests are submitted through NaviMedic or the Aetna clinical reviewer line listed on the denial determination letter. For United Healthcare, contact the UHC clinical reviewer line printed on the UM denial. For Cigna, peer-to-peer requests are submitted through the Cigna for Health Professionals portal with a clinical reviewer scheduling request. The REI physician should review the payer's clinical policy document for the specific case before the call so the conversation directly addresses the criteria the plan medical director used to generate the denial, rather than speaking broadly about IVF as a treatment modality. Peer-to-peer calls that result in overturn of the denial must be documented in the practice management system with the medical director's name and credentials, the date of the call, the specific determination reversed, and the authorization number or reversal reference number issued during or after the call.

Tracking Appeal Outcomes and Improving Your First-Pass Claim Rate

An IVF appeal program without outcome tracking is operating without feedback. Practices that track appeal outcomes by denial reason code, payer, appeal level, and clinical indication generate data that drives measurable improvement in their first-pass claim rate over time — because the denials that survive multiple appeal levels most frequently point to front-end billing process failures (wrong ICD-10 code for the patient's documented diagnosis, authorization step skipped, incorrect place of service on surgical retrieval claim) that can be corrected prospectively to prevent the same denial pattern from recurring on future claims. Practices that do not track appeal outcomes repeat the same billing errors indefinitely, treating each denial as an isolated event rather than as diagnostic data about a correctable process gap.

Target metrics for a well-functioning IVF appeal program: first-level internal appeal overturn rate above 55% for clinical denials; corrected claim resolution rate above 85% for administrative resubmissions; peer-to-peer overturn rate above 40%; and external independent review organization (IRO) overturn rate above 30%. Any payer where the first-level appeal overturn rate falls below 40% for two consecutive quarters should be reviewed to determine whether the appeal template in use addresses the current version of that payer's medical necessity policy — payer policies update quarterly, and a template effective against a 2024 version of a payer's IVF criteria may cite superseded language that no longer corresponds to the current adjudication standard, producing denials that appear inexplicable until the policy revision is identified, the template is updated, and pending appeals are redrafted against the current criteria.